LivaNova (LIVN) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.00 |
| Dec 31, 2025 | -13.00 |
| Sep 30, 2025 | 109.00 |
| Jun 30, 2025 | 127.00 |
| Mar 31, 2025 | 293.00 |
| Dec 31, 2024 | 579.00 |
| Sep 30, 2024 | 230.00 |
| Jun 30, 2024 | 36.00 |
| Mar 31, 2024 | 99.00 |
| Dec 31, 2023 | -499.00 |
| Sep 30, 2023 | 671.00 |
| Jun 30, 2023 | -60.00 |
| Mar 31, 2023 | -55.00 |
| Dec 31, 2022 | -60.00 |
| Sep 30, 2022 | -722.00 |
| Jun 30, 2022 | 318.00 |
| Mar 31, 2022 | 77.00 |
| Dec 31, 2021 | 1,667.00 |
| Sep 30, 2021 | 104.00 |
| Jun 30, 2021 | -441.00 |
| Mar 31, 2021 | -63.00 |
| Dec 31, 2020 | -516.00 |
| Sep 30, 2020 | -144.00 |
| Jun 30, 2020 | 168.00 |
| Mar 31, 2020 | 86.00 |
| Dec 31, 2019 | 571.00 |
| Sep 30, 2019 | 215.00 |
| Jun 30, 2019 | -211.00 |
| Mar 31, 2019 | -251.00 |
| Dec 31, 2018 | -1,400.00 |
| Sep 30, 2018 | -154.00 |
| Jun 30, 2018 | -52.00 |
| Mar 31, 2018 | -33.00 |
| Dec 31, 2017 | 166.00 |
| Sep 30, 2017 | -15.00 |
| Jun 30, 2017 | 2.00 |
| Mar 31, 2017 | 145.00 |
| Dec 31, 2016 | 61.00 |
| Sep 30, 2016 | 42.00 |
| Jun 30, 2016 | 37.00 |